|29.71||-1.71 / -5.44%|
As of 4:00pm ET
|29.71||-0.0001 / -0.00%|
The 7 analysts offering 12-month price forecasts for Acorda Therapeutics Inc have a median target of 42.00, with a high estimate of 65.00 and a low estimate of 32.00. The median estimate represents a +41.37% increase from the last price of 29.71.
The current consensus among 9 polled investment analysts is to Hold stock in Acorda Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.